What is ISoP?
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…
ISoP Training
Mid Year Training
Nairobi, Kenya,
6-8 May 2019
Pharmacovigilance in Africa beyond spontaneous reports.
ISoP-UMC
7th ISoP-UMC Training
Guangzhou, China,
11-12 November 2019
Pharmacovigilance systems in China: Moving to the next step.
REGISTER NOW
ISoP 2019
Annual Meeting
Bogota, Colombia
26-29 October 2019
New opportunities for new generations.
REGISTER NOW
ISoP Chapters Meetings
Latin America Meeting
09-10 May 2019
READ MORE
North America Meeting
02 November 2018
READ MORE
Israel Meeting
03-04 June 2019
READ MORE
ISoP Seminar
ISoP Seminar 2019
NOTE: Change of date.
Boston, USA,
2-3 December 2019
Intelligent Automation in Pharmacovigilance.
ISoP ETP
Education Training Programme
Education Training Programme
A primary objective of ISoP is to promote the safest use of drugs through contributing to appropriate education.
ISoP 2018
Annual Meeting
Geneva, Switzerland,
11-14 November 2018
Pharmacovigilance without borders.
Most Presentations now available – click here.
What’s New
ISoP President, S. Olsson, was appointed on 11th July by WHO Director-General to serve for a period of four years as a member of the WHO Expert Advisory Panel on Medicine Safety.
‘Manual de Buenas Prácticas de Farmacovigilancia’
Role and strategy of ISoP in global pharmacovigilance
Article published in Int. Journal of Clinical Pharmacy
Updated ISoP Privacy Policy
In line with the new General Data Protection Regulation (GDPR)
ISoP webinars
Recorded webinars with Nitin Joshi, editor in chief of Drug Safety are now available to ISoP members
Medication Errors Group
More information, click here
Medical Devices Group
More information, click here
EMA discussion paper
Use of patient disease registers for regulatory purposes. For public consultation (09/11/2018)
